
The Compounded GLP-1 Crisis: What Pharmacies, Telehealth Companies, and Prescribers Need to Know About Federal Exposure
FDA resolved the semaglutide and tirzepatide shortages in 2025. The sales kept going. Where prosecutors start, what they charge, and what to do first.












